Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.
Institute for Biomedical Engineering, ETH, Zürich, Switzerland.
Br J Cancer. 2020 Jul;123(2):216-225. doi: 10.1038/s41416-020-0878-7. Epub 2020 May 11.
The extracellular matrix modulates the development of ovarian tumours. Currently, evaluation of the extracellular matrix in the ovary is limited to histological methods. Both magnetic resonance imaging (MRI) and two-photon microscopy (2PM) enable dynamic visualisation and quantification of fibrosis by endogenous contrast mechanisms: magnetisation transfer (MT) MRI and second-harmonic generation (SHG) 2PM, respectively.
Here, we applied the MT-MRI protocol for longitudinal imaging of the stroma in orthotopic human ovarian cancer ES-2 xenograft model in CD1 athymic nude mice, and for orthotopically implanted ovarian PDX using a MR-compatible imaging window chamber implanted into NSG mice.
We observed differences between ECM deposition in ovarian and skin lesions, and heterogeneous collagen distribution in ES-2 lesions. An MR-compatible imaging window chamber enabled visual matching between T2 MRI maps of orthotopically implanted PDX grafts and anatomical images of their microenvironment acquired with a stereomicroscope and SHG-2PM intravital microscopy of the collagen. Bimodal MRI/2PM imaging allowed us to quantify the fibrosis within the same compartments, and demonstrated the consistent results across the modalities.
This work demonstrates a novel approach for measuring the stromal biomarkers in orthotopic ovarian tumours in mice, on both macroscopic and microscopic levels.
细胞外基质调节卵巢肿瘤的发展。目前,对卵巢细胞外基质的评估仅限于组织学方法。磁共振成像(MRI)和双光子显微镜(2PM)都能够通过内源性对比机制动态可视化和量化纤维化:磁化传递(MT)MRI 和二次谐波产生(SHG)2PM。
在这里,我们应用 MT-MRI 方案对 CD1 裸鼠的原位人卵巢癌 ES-2 异种移植模型的基质进行纵向成像,并用植入 NSG 小鼠的 MR 兼容成像窗室对原位植入的卵巢 PDX 进行成像。
我们观察到卵巢和皮肤病变中细胞外基质沉积的差异,以及 ES-2 病变中胶原的不均匀分布。MR 兼容成像窗室能够在立体显微镜获得的同种异体植入 PDX 移植物的 T2 MRI 图谱和其微环境的解剖图像之间进行视觉匹配,并通过共聚焦显微镜和 SHG-2PM 活体显微镜对胶原进行体内成像。双模态 MRI/2PM 成像允许我们在相同的隔室中定量纤维化,并证明了两种模式的一致结果。
这项工作展示了一种在小鼠原位卵巢肿瘤中测量基质生物标志物的新方法,可在宏观和微观水平上进行。